Protect Your Patients, Your License, and Your Margins The FDA says BPC-157 isn't approved for patients right now
Since mitochondria are essential to our very existence, it is unsurprising that the effects of mitochondrial diseases can be severe, and sometimes lethal, spanning a wide-ranging spectrum of physiological and biochemical symptoms [1,3,4] (see Table 1 for examples)
Non-selective NSAIDs (aspirin, naproxen [e.g., Aleve], ibuprofen [e.g., Advil], diclofenac [e.g., Cambia], and indomethacin [Indocin]) inhibit the activity of both COX enzymes (Conaghan 2012)
Thanks Tim K
But it doesn't end there
Avoid repeated freeze-thaw cycles, which reduce recovery of the 43-residue thymosin beta 4 chain in particular, label every aliquot with the reconstitution date, and handle throughout under sterile laboratory conditions